# FDA Inspection 1285720 - Biomat USA, Inc. - October 10, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/c1039a54-766d-41ae-bc61-5014f2a26403
Source feed: FDA_Inspections

> FDA Inspection 1285720 for Biomat USA, Inc. on October 10, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1285720
- Company Name: Biomat USA, Inc.
- Inspection Date: 2025-10-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1285720 - 2025-10-10](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/f7d19df3-1eff-44e9-8b77-a6525118d471)
- [FDA Inspection 1122663 - 2020-03-12](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/6739821f-d42c-4000-9e1e-19eb85fe61e3)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/de2e361d-9eff-435f-9d0c-0acbf70be0bd

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d